PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Sep-2025 Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting ABIVAX
26-Sep-2025 Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial (news with additional features) Pentixapharm Holding AG
25-Sep-2025 Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma Heidelberg Pharma AG
25-Sep-2025 Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis Immunic AG
25-Sep-2025 Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment Heidelberg Pharma AG
25-Sep-2025 Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment Heidelberg Pharma AG
24-Sep-2025 Cambridge Network launches Graduate Scheme to develop future leaders Cambridge Network
24-Sep-2025 Gerresheimer comments on the audit by German BaFin Gerresheimer AG
23-Sep-2025 Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting ABIVAX
23-Sep-2025 Neuraxpharm participates in ECTRIMS, reinforcing its commitment to multiple sclerosis Neuraxpharm Group
23-Sep-2025 Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland Mainz BioMed N.V.
23-Sep-2025 Viromed Medical AG initiates approval process for PulmoPlas® with the Federal Institute for Drugs and Medical Devices (BfArM) Viromed Medical AG
23-Sep-2025 Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Sanofi
23-Sep-2025 Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization Xlife Sciences AG
22-Sep-2025 PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out PharmaSGP Holding SE
22-Sep-2025 PolyPeptide Group achieves significant milestone in Malmö expansion project PolyPeptide Group
19-Sep-2025 aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year aap Implantate AG
19-Sep-2025 Biotest AG: Extraordinary general meeting convened at the request of Grifols S.A. Biotest AG
19-Sep-2025 Eckert & Ziegler Gains Approval for GalliaPharm® in Japan Eckert & Ziegler SE
18-Sep-2025 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG